Principal Investigator
Robert Kirsner
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240708
Clinical Trial Summary
A multicenter, prospective, randomized, placebo controlled, double blind, adaptive design study performed to evaluate the safety and efficacy of EscharEx (EX-03 formulation) in debridement of Venous Leg Ulcers
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other